Mohammed Gbadamosi

MGbadamosiContact Information

Email: mgbadamosi@ufl.edu

Education

B.Sc, University of Delaware – Newark, DE

Entry date into PTR PhD Program: Fall 2017
Curriculum Vitae

 

 

Research Interests

  • Pharmacogenomics
  • Personalized Medicine
  • AML
  • Cancer Genomics
  • Immunotherapy
  • Pediatric Leukemia

Scholarship/Awards

  • Graduate School Preeminence Award
  • McKnight Graduate Fellowship Affiliate
  • Board of Education Summer Fellowship

Professional Memberships

  • American Society for Clinical Pharmacology and Therapeutics (ASCPT) 
  • American Society of Hematology (ASH)
  • National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE)

Publications

  • Gbadamosi M, Meishinchi S, Lamba JK. Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia. Future Oncology. [In Review].